During the last 20 years, pharmaceutical industry and academic eforts have led to several structurally unrelated classes of non peptide cholecystokinin-1 receptor antagonista. Due to the lack of high resolution structure of CCK1-R and its peptide ligand, different strategies to design antagonists have been adopted.

TWENTY YEARS OF NON-PEPTIDE CCK1 RECEPTOR ANTAGONISTS: ALL THAT GLITTERS IS NOT GOLD / Lassiani, Lucia; Varnavas, Antonios. - In: EXPERT OPINION ON THERAPEUTIC PATENTS. - ISSN 1354-3776. - STAMPA. - 16:(2006), pp. 1193-1213. [10.1517/13543776.16.9.1193]

TWENTY YEARS OF NON-PEPTIDE CCK1 RECEPTOR ANTAGONISTS: ALL THAT GLITTERS IS NOT GOLD

LASSIANI, LUCIA;VARNAVAS, ANTONIOS
2006-01-01

Abstract

During the last 20 years, pharmaceutical industry and academic eforts have led to several structurally unrelated classes of non peptide cholecystokinin-1 receptor antagonista. Due to the lack of high resolution structure of CCK1-R and its peptide ligand, different strategies to design antagonists have been adopted.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/1707981
 Avviso

Registrazione in corso di verifica.
La registrazione di questo prodotto non è ancora stata validata in ArTS.

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? ND
social impact